In the BioHarmony Drug Report Database

"Preview" Icon

Dulaglutide

Trulicity (dulaglutide) is a protein pharmaceutical. Dulaglutide was first approved as Trulicity on 2014-09-18. It is used to treat type 2 diabetes mellitus in the USA. It has been approved in Europe to treat type 2 diabetes mellitus.

 

Trade Name

 

Trulicity
 

Common Name

 

dulaglutide
 

ChEMBL ID

 

CHEMBL2108027
 

Indication

 

type 2 diabetes mellitus
 

Drug Class

 

Peptides: GLP peptide analogs

Image (chem structure or protein)

Dulaglutide structure rendering